# Casa Sollievo della Sofferenza

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/casa-sollievo-della-sofferenza/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 52.8 |
| Citations | 1,065,173 |
| City | San Giovanni Rotondo |
| Country | IT |
| Description | Casa Sollievo della Sofferenza is a research organisation in San Giovanni Rotondo, IT. OpenAlex records 10,439 works and 1,065,173 citations for it. 1,444 researchers list it as their most recent affiliation. |
| Homepage | http://www.operapadrepio.it/en/ |
| OpenAlex ID | https://openalex.org/I2800188116 |
| Researchers | 1,444 |
| ROR ID | https://ror.org/00md77g41 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q1213805 |
| Works | 10,439 |

## University papers

Showing 12 of 30.

- [The 2017 international classification of the Ehlers–Danlos syndromes](https://scholariq.org/papers/the-2017-international-classification-of-the-ehlers-danlos-syndromes/)
- [A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis](https://scholariq.org/papers/a-phase-3-randomized-controlled-trial-of-resmetirom-in-nash-with-liver-fibrosis/)
- [Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies](https://scholariq.org/papers/incidence-rates-of-post-ercp-complications-a-systematic-survey-of-prospective/)
- [Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma](https://scholariq.org/papers/adapted-treatment-guided-by-interim-pet-ct-scan-in-advanced-hodgkin-s-lymphoma/)
- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014](https://scholariq.org/papers/prophylaxis-of-post-ercp-pancreatitis-european-society-of-gastrointestinal/)
- [Common variants at five new loci associated with early-onset inflammatory bowel disease](https://scholariq.org/papers/common-variants-at-five-new-loci-associated-with-early-onset-inflammatory-bowel/)
- [Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis](https://scholariq.org/papers/genome-wide-meta-analyses-identify-three-loci-associated-with-primary-biliary/)
- [Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease](https://scholariq.org/papers/metabolic-cognitive-syndrome-a-cross-talk-between-metabolic-syndrome-and/)
- [International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways](https://scholariq.org/papers/international-genome-wide-meta-analysis-identifies-new-primary-biliary-cirrhosis/)
- [R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi](https://scholariq.org/papers/r-cvp-versus-r-chop-versus-r-fm-for-the-initial-treatment-of-patients-with/)
- [Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials](https://scholariq.org/papers/radiofrequency-thermal-ablation-vs-percutaneous-ethanol-injection-for-small/)

## University researchers

- [Grazia D’Onofrio](https://scholariq.org/researchers/grazia-d-onofrio/)
- [Daniele Sancarlo](https://scholariq.org/researchers/daniele-sancarlo/)

## University top topics

Showing 8 of 25.

- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
